Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debbie Hicks

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 9, 2019
Optimising the Benefits of SGLT2 Inhibitors for Type 1 DiabetesMarc Evans, Debbie Hicks, Dipesh Patel, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 2, 2020
Correction to: Optimising the Benefits of SGLT2 Inhibitors for Type 1 DiabetesMarc Evans, Debbie Hicks, Dipesh Patel, et al.
Eclinicalmedicine|February 20, 2024
The clinical significance of sub-total surgical resection in childhood medulloblastoma: a multi-cohort analysis of 1100 patientsClaire Keeling, Simon Davies, Jack Goddard, et al.
Acta Neuropathologica Communications|June 24, 2025
Robust molecular subgrouping and reference-free aneuploidy detection in medulloblastoma using low-depth whole genome bisulfite sequencingDean Thompson, Jemma Castle, Martin Sill, et al.
Journal of Neurology|April 25, 2012
Myopathy caused by anoctamin 5 mutations and necrotizing vasculitisIsabelle Pénisson-Besnier, Jean-Paul Saint-André, Debbie Hicks, et al.
The Lancet. Diabetes & Endocrinology|August 9, 2015
The revised NICE draft guideline for type 2 diabetes: still a long way to goJ Paul O'Hare, David Millar-Jones, Wasim Hanif, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 25, 2018
SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical PracticeJohn Wilding, Kevin Fernando, Nicola Milne, et al.
Current Medical Research and Opinion|July 26, 2011
A look into the future: improving diabetes care by 2015Stephen Brunton, Stephen Gough, Debbie Hicks, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 30, 2020
SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 DiabetesDavid C Wheeler, June James, Dipesh Patel, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 20, 2019
Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into PracticeAmar Ali, Steve Bain, Debbie Hicks, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 9, 2019
Optimising the Benefits of SGLT2 Inhibitors for Type 1 DiabetesMarc Evans, Debbie Hicks, Dipesh Patel, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 2, 2020
Correction to: Optimising the Benefits of SGLT2 Inhibitors for Type 1 DiabetesMarc Evans, Debbie Hicks, Dipesh Patel, et al.
Eclinicalmedicine|February 20, 2024
The clinical significance of sub-total surgical resection in childhood medulloblastoma: a multi-cohort analysis of 1100 patientsClaire Keeling, Simon Davies, Jack Goddard, et al.
Acta Neuropathologica Communications|June 24, 2025
Robust molecular subgrouping and reference-free aneuploidy detection in medulloblastoma using low-depth whole genome bisulfite sequencingDean Thompson, Jemma Castle, Martin Sill, et al.
Journal of Neurology|April 25, 2012
Myopathy caused by anoctamin 5 mutations and necrotizing vasculitisIsabelle Pénisson-Besnier, Jean-Paul Saint-André, Debbie Hicks, et al.
The Lancet. Diabetes & Endocrinology|August 9, 2015
The revised NICE draft guideline for type 2 diabetes: still a long way to goJ Paul O'Hare, David Millar-Jones, Wasim Hanif, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 25, 2018
SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical PracticeJohn Wilding, Kevin Fernando, Nicola Milne, et al.
Current Medical Research and Opinion|July 26, 2011
A look into the future: improving diabetes care by 2015Stephen Brunton, Stephen Gough, Debbie Hicks, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 30, 2020
SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 DiabetesDavid C Wheeler, June James, Dipesh Patel, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 20, 2019
Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into PracticeAmar Ali, Steve Bain, Debbie Hicks, et al.
Pageof 6